4.8.4.5Vertical
X-Ray & Fluoroscopy Systems
Conventional X-ray and real-time fluoroscopy imaging equipment.
Market snapshot
These figures describe Diagnostic Imaging Equipment (4.8.4), the segment that X-Ray & Fluoroscopy Systems sits within — not X-Ray & Fluoroscopy Systems on its own.
- Market size
- ~$32B
- Growth
- ~6.3%CAGR (2017–22, nominal)
- Companies
- ~390
FragmentationConsolidatedEstimate
U.S. Census Bureau 2022 CBP/Economic Census, NAICS 325413 (In-Vitro Diagnostics) + 334517 (Irradiation Apparatus); broader imaging electronics span other codes.
Business model & economics
Revenue model
Capital equipment plus recurring service and consumables
Key economics
- Recurring revenue
- Moderate–High
- EBITDA margin
- 15–25%
- Capex intensity
- High
service contracts and reagents
Characteristics
- Consolidated oligopoly in imaging systems.
- AI-enabled imaging and point-of-care innovation.
- Recurring service and contrast/reagent revenue.
M&A deal context
Deal activityModerate
Who’s acquiring
- Imaging & diagnostics strategics
- AI-imaging acquirers
- Diagnostics platforms
What’s driving deals
- AI-imaging and point-of-care acquisitions.
- Diagnostics expansion and replacement cycles.
- Recurring service and consumables economics.
Find X-Ray & Fluoroscopy Systems acquisition targets
Search Acquisera’s index for companies classified under X-Ray & Fluoroscopy Systems (4.8.4.5) and build a targeted deal pipeline.
Search companies